The analysis of p62 expression in patients with TCGA‐LGG revealed that heightened p62 expression is associated with reduced overall survival (Figure 3E), higher glioma grades (Figure 3F), and increased prevalence in IDH wild‐type status (Figure 3G). This evidence concerns the gene SQSTM1 and central nervous system cancer.